Product Information
PRAMIPEXOLE 0.125 MG TABLET is a generic product labeled by Strides Pharma Inc., priced at $0.0425 per EA under NDC 64380074605. Its NADAC has been published 268 times since May 12, 2021.
Strength
.125 mg/1
Manufacturer
Strides Pharma Inc.NDC
64380074605
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PRAMIPEXOLE DIHYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202702On Market Since
2/15/2021
Pharmacological Classes
Price Statistics
The NADAC for PRAMIPEXOLE 0.125 MG TABLET has been published 268 times since May 12, 2021, and over the history we have for it it has declined 15.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0425 per EA |
|---|---|
| All-time high | $0.0595 (Jan 12, 2022) |
| All-time low | $0.0350 (Nov 20, 2024) |
| 52-week high | $0.0460 |
| 52-week low | $0.0404 |
| Median price | $0.0483 |
| Average price | $0.0479 |
| Largest weekly change | +23.8% (Aug 21, 2024) |
| Weeks tracked | 268 |
| Tracking since | May 12, 2021 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the pramipexole dihydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of PRAMIPEXOLE 0.125 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for PRAMIPEXOLE 0.125 MG TABLET, manufactured by Strides Pharma Inc., is $0.0425 per EA (NDC 64380074605), effective Jun 24, 2026.
How has the price of PRAMIPEXOLE 0.125 MG TABLET changed over time?
Over the history we have for it, the NADAC for PRAMIPEXOLE 0.125 MG TABLET has declined 15.2%. It has been tracked across 268 weekly CMS publications since May 12, 2021.
What are the highest and lowest recorded NADAC prices for PRAMIPEXOLE 0.125 MG TABLET?
Since May 12, 2021, the NADAC for PRAMIPEXOLE 0.125 MG TABLET has ranged from a low of $0.0350 (Nov 20, 2024) to a high of $0.0595 (Jan 12, 2022), with a median of $0.0483 per EA.
Are there cheaper alternatives to PRAMIPEXOLE 0.125 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of PRAMIPEXOLE 0.125 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures PRAMIPEXOLE 0.125 MG TABLET?
PRAMIPEXOLE 0.125 MG TABLET (NDC 64380074605) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification